Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes — Stella

Home/Myocardial Infarction/

View on ClinicalTrials.gov

Recruiting

Back to Myocardial Infarction trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Brazil

Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, São Paulo

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

University of Sao Paulo

Enrollment target

~80 participants

Started

December 2021

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.